<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01616069</url>
  </required_header>
  <id_info>
    <org_study_id>0362/14-12-2011</org_study_id>
    <nct_id>NCT01616069</nct_id>
  </id_info>
  <brief_title>Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography</brief_title>
  <official_title>Assessment and Hemodynamic Response in CABG After Cardiopulmonary Bypass Using Intraoperative Transesophegeal Echocardiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Juiz de Fora</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Cardiology/Ministry of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of Juiz de Fora</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double blind randomization study, assessing hemodynamic response in patients who
      underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using
      intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be
      batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan
      will be assessment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic and diastolic heart function</measure>
    <time_frame>Two years</time_frame>
    <description>Assessment the systolic and diastolic heart function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality after CABAG</measure>
    <time_frame>Two years</time_frame>
    <description>Assessment mortality after CABAG</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">81</enrollment>
  <condition>Cardiopulmonary Bypass Graft</condition>
  <arm_group>
    <arm_group_label>epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Assessment of systolic and diastolic heart function during CABAG with CPB with levosimendan using TEE.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levosimendan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Assessment of systolic and diastolic heart function during CABAG with CPB with epinephrine using TEE.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epinephrine and levosimendan</intervention_name>
    <description>epinephrine (0,06mcg/kg/min), levosimendan (0,2 mcg/kg/min)</description>
    <arm_group_label>epinephrine</arm_group_label>
    <arm_group_label>levosimendan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sinusal ritmus

          -  EF &gt; 35%

          -  Elective CABG surgery

        Exclusion Criteria:

          -  No accept

          -  Severe valvular regurgitation or stenoses

          -  Chest pain

          -  Cardiogenic shock
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcello F Salgado Filho, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Cardiology/Ministry of Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institute of Cardiology / Ministry of Health</name>
      <address>
        <city>Rio de janeiro</city>
        <state>RJ</state>
        <zip>3600-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.sba.com.br</url>
  </link>
  <link>
    <url>http://www.pubmed.com</url>
  </link>
  <link>
    <url>http://www.scahq.org</url>
  </link>
  <results_reference>
    <citation>Chung PC, Huang PC, Liu YF, Chen KB. Transesophageal echocardiography, more than a diagnostic tool: use during surgical ligation of coronary artery fistulae - a case report. J Cardiothorac Surg. 2012 Apr 6;7:28. doi: 10.1186/1749-8090-7-28.</citation>
    <PMID>22480207</PMID>
  </results_reference>
  <results_reference>
    <citation>De Mey N, Couture P, Laflamme M, Denault AY, Perrault LP, Deschamps A, Rochon AG. Intraoperative changes in regional wall motion: can postoperative coronary artery bypass graft failure be predicted? J Cardiothorac Vasc Anesth. 2012 Jun;26(3):371-5. doi: 10.1053/j.jvca.2012.02.005. Epub 2012 Mar 28.</citation>
    <PMID>22459932</PMID>
  </results_reference>
  <results_reference>
    <citation>Salgado Filho MF, Siciliano A, Siciliano A, Oliveira AJ, Salgado J, Palitot I. The importance of transesophageal echocardiography in heart harvesting for cardiac transplantation. Rev Bras Anestesiol. 2012 Mar-Apr;62(2):262-8. doi: 10.1016/S0034-7094(12)70124-1.</citation>
    <PMID>22440381</PMID>
  </results_reference>
  <results_reference>
    <citation>Fattouch K, Castrovinci S, Murana G, Novo G, Caccamo G, Bertolino EC, Sampognaro R, Novo S, Ruvolo G, Lancellotti P. Multiplane two-dimensional versus real time three-dimensional transesophageal echocardiography in ischemic mitral regurgitation. Echocardiography. 2011 Nov;28(10):1125-32. doi: 10.1111/j.1540-8175.2011.01528.x. Epub 2011 Oct 17.</citation>
    <PMID>22004267</PMID>
  </results_reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2012</study_first_submitted>
  <study_first_submitted_qc>June 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2012</study_first_posted>
  <last_update_submitted>May 29, 2015</last_update_submitted>
  <last_update_submitted_qc>May 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Rio de Janeiro</investigator_affiliation>
    <investigator_full_name>Marcello F Salgado Filho, MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>CABG</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Heart Function</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Simendan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

